COMMUNIQUÉS West-GlobeNewswire

Cognition Therapeutics Releases New Episode of “Conversations” Podcast: Studying the Patient/Caregiver Lived Experience in Dementia with Lewy Bodies
28/05/2025
PURCHASE, N.Y., May 28, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, has released [...]
R1 Announces Investment from Khosla Ventures as it Accelerates AI-Driven Healthcare Transformation
28/05/2025
Investment Follows Recent R37 Launch MURRAY, Utah, May 28, 2025 (GLOBE NEWSWIRE) -- R1, an industry leader in managing and intelligently automating healthcare revenue management with over 20 years of experience, today [...]
Rezolute Announces Completion of Enrollment in the Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism
28/05/2025
Target enrollment exceeded with 62 participants enrolled, including approximately 15 percent from U.S. sites Topline data is anticipated in December of 2025 REDWOOD CITY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- [...]
Vaxart Answers Additional Frequently Asked Questions from Retail Investors
28/05/2025
Company Urges Stockholders to Vote FOR Reverse Stock Split Proposal by 11:59 p.m. Eastern Time on June 1, 2025 SOUTH SAN FRANCISCO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the “Company” OR [...]
Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference
28/05/2025
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with [...]
Milestone Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
28/05/2025
MONTREAL AND CHARLOTTE, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that Amit Hasija, Chief Financial Officer, and Lorenz Muller, Chief Commercial Officer, will [...]
BetterLife Pharma Provides Scientific Update on Neuroplastogenic Activity of BETR-001
28/05/2025
VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) ( CSE: BETR / OTCQB : BETRF / FRA: NPAU ), an emerging biotech company focused on the development of [...]
Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference
28/05/2025
BOSTON, May 28, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today announced that [...]
Solid Biosciences to Participate at the Jefferies Global Healthcare Conference
28/05/2025
CHARLESTOWN, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac [...]
Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer
28/05/2025
Dr. Wright brings deep experience across a wide breadth of therapeutic areas and modalities and will guide clinical development of Wave’s robust RNA medicines pipeline CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- [...]
Design Therapeutics to Participate in 2025 Jefferies Global Healthcare Conference
28/05/2025
CARLSBAD, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that [...]
Bright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare Conference
28/05/2025
NEW YORK and VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG), a pioneering company focused on developing highly [...]
Yerbaé Joins TikTok Shop to Accelerate Growth and Expand Digital Reach
28/05/2025
SCOTTSDALE, Ariz., May 28, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc . (Nasdaq: SHOT) (“SHOT”, "Safety Shot”, or the “Company”), a wellness and dietary supplement company, announces its acquisition partner, Yerbaé [...]
ABLi Therapeutics Strengthens Leadership Team and Board of Directors
28/05/2025
Directors Appointed from Senior Leadership Teams of J&J and Atalanta Appointment of Chief Operating Officer Continues Building of Neuroscience Focused Team of Accomplished Professionals ATLANTA and BOSTON, May 28, [...]
Cocrystal Pharma to Participate in Noble Capital Markets’ 2025 Emerging Growth Virtual Equity Conference
28/05/2025
BOTHELL, Wash., May 28, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc . (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that management will participate in a fireside chat during the Noble Capital Markets’ 2025 [...]
Un avenir où la santé des femmes est une priorité : La Fondation du CUSM lance un mouvement de 5 M$ pour changer l’avenir des soins
28/05/2025
MONTRÉAL, 28 mai 2025 (GLOBE NEWSWIRE) -- Les femmes méritent des soins de santé pensés pour elles. Elles méritent de faire partie intégrante de la recherche, de recevoir des soins adaptés à leurs besoins et d’avoir [...]
A Future Where Women’s Health Leads: The MUHC Foundation Launches $5 Million Movement for Change
28/05/2025
MONTREAL, May 28, 2025 (GLOBE NEWSWIRE) -- Women deserve health care designed with them in mind. They deserve research that includes them, care that reflects their needs, and a future where their well-being is a top [...]
Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference
28/05/2025
ALACHUA, Fla. and TAMPA, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that [...]
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
28/05/2025
WEST CHESTER, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical [...]

Pages